Stockscreener 앱 받기
82.60
0.12%
-0.10
시간 외 거래:
82.80
0.20
+0.24%
전일 마감가:
$82.70
열려 있는:
$82.51
하루 거래량:
5.94M
Relative Volume:
0.82
시가총액:
$108.02B
수익:
$33.20B
순이익/손실:
$4.26B
주가수익비율:
25.11
EPS:
3.29
순현금흐름:
$5.47B
1주 성능:
+0.07%
1개월 성능:
-11.52%
6개월 성능:
-8.01%
1년 성능:
+4.45%
1일 변동 폭
$82.12
$83.32
1주일 범위
$81.18
$84.73
52주 변동 폭
$75.96
$96.25
메드트로닉 Stock (MDT) Company Profile
명칭
Medtronic Plc
전화
01135314381700
주소
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
MDT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MDT
Medtronic Plc
|
82.60 | 108.02B | 33.20B | 4.26B | 5.47B | 3.29 |
|
ABT
Abbott Laboratories
|
130.98 | 221.92B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.12 | 139.43B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
346.50 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
EW
Edwards Lifesciences Corp
|
71.53 | 40.93B | 5.72B | 4.17B | 259.90M | 6.97 |
메드트로닉 Stock (MDT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-04 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-10-10 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-08-21 | 재확인 | Oppenheimer | Perform |
| 2024-08-15 | 업그레이드 | UBS | Sell → Neutral |
| 2024-08-14 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-05-30 | 개시 | Goldman | Sell |
| 2023-07-19 | 개시 | Robert W. Baird | Neutral |
| 2023-06-30 | 개시 | CL King | Buy |
| 2023-05-30 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-24 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-03-29 | 다운그레이드 | UBS | Buy → Sell |
| 2023-01-09 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-11-23 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-11-23 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2022-11-16 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2022-10-18 | 개시 | Barclays | Equal Weight |
| 2022-10-13 | 개시 | Mizuho | Buy |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-08-24 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2022-07-06 | 개시 | Wolfe Research | Underperform |
| 2022-06-01 | 다운그레이드 | Atlantic Equities | Overweight → Neutral |
| 2022-05-27 | 다운그레이드 | Needham | Buy → Hold |
| 2022-04-13 | 다운그레이드 | Truist | Buy → Hold |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-01-10 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2022-01-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-12-17 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-12-16 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-06-10 | 재개 | Cowen | Outperform |
| 2021-05-25 | 개시 | Barclays | Equal Weight |
| 2021-04-15 | 개시 | Atlantic Equities | Overweight |
| 2020-12-15 | 업그레이드 | Goldman | Sell → Neutral |
| 2020-12-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-10-08 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2020-10-08 | 업그레이드 | Stifel | Hold → Buy |
| 2020-09-11 | 개시 | Wolfe Research | Peer Perform |
| 2020-05-14 | 다운그레이드 | DZ Bank | Buy → Hold |
| 2020-03-30 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2020-03-25 | 업그레이드 | DZ Bank | Hold → Buy |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Sell |
| 2020-01-08 | 개시 | SunTrust | Buy |
| 2020-01-02 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2019-06-05 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2019-02-04 | 재확인 | Needham | Strong Buy |
| 2019-01-03 | 개시 | Deutsche Bank | Buy |
| 2019-01-02 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2018-12-19 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-11-28 | 개시 | UBS | Buy |
| 2018-10-16 | 개시 | Barclays | Overweight |
| 2018-08-27 | 재확인 | Argus | Buy |
모두보기
메드트로닉 주식(MDT)의 최신 뉴스
New Simplera Sync™ sensor for the MiniMed™ 780G System now FDA approved - Medtronic
FDA Approves Revolutionary Diabetes Sensor: Medtronic's New Tech Eliminates Fingersticks, Simplifies Management - Stock Titan
Medtronic (MDT) Stock Dips While Market Gains: Key Facts - Nasdaq
Medtronic (MDT) Faces Tariff Risks Amid Global Trade Changes - GuruFocus
Barclays Flags Medtronic, J&J as Most at Risk from Looming Pharma Tariffs - Yahoo Finance
Medtronic plc (MDT): A Bull Case Theory - Insider Monkey
Spinal Column Market Deep Research Report with Forecast by 2032 | - openPR.com
Tariffs top of mind for medtech firms this earnings season - MedTech Dive
Medtronic: Rock 'n' Roll Dad's New Music Inspired by Son's Diagnosis - Yahoo Finance
Is Now An Opportune Moment To Examine Medtronic plc (NYSE:MDT)? - simplywall.st
Medtronic (MDT) Gains But Lags Market: What You Should Know - Yahoo Finance
Truist Trims Price Target on Medtronic to $90 From $93, Keeps Hold Rating - MarketScreener
Baird Adjusts Price Target on Medtronic to $94 From $91, Maintains Neutral Rating - MarketScreener
Intramedullary Nail Market size to worth USD 1,537 Million by 2032, says Coherent Market Insights - GlobeNewswire Inc.
Medtronic Becomes Oversold - Nasdaq
Medtronic's MiniMed 780G Leads in Time in Target Range for Type 1 Diabetes - Medical Device and Diagnostic industry
Citigroup Adjusts Medtronic Price Target to $103 From $107, Maintains Buy Rating - MarketScreener
Looking Into Medtronic's Recent Short Interest - Benzinga
Medtronic PLC (MDT) Shares Gap Down to $84.31 on Apr 4 - GuruFocus
Piper Sandler maintains Medtronic stock neutral with $90 target By Investing.com - Investing.com UK
Medtronic (MDT) Stock Moves -1.09%: What You Should Know - Nasdaq
May 23rd Options Now Available For Medtronic (MDT) - Nasdaq
Boston Scientific’s Farapulse matches Medtronic cryoablation in trial - MedTech Dive
Medtronic (MDT) Advances But Underperforms Market: Key Facts - Yahoo Finance
Former Medtronic CEO Criticizes RFK Jr.'s HHS Leadership - Medical Device and Diagnostic industry
Medtronic, Recor commence hostilities over RDN patents - BioWorld MedTech
3 takeaways from ACC 2025 - MedTech Dive
Evercore ISI Adjusts Medtronic Price Target to $105 From $104, Maintains Outperform Rating - MarketScreener
Boston Scientific’s Farapulse Triumphs Over Medtronic’s Artic Front in Atrial Fibrillation Trial - Medical Device and Diagnostic industry
The Zacks Analyst Blog Highlights Mastercard, Medtronic, HCA Healthcare and United Homes - Nasdaq
Medtronic plc (NYSE:MDT) Stake Boosted by Geode Capital Management LLC - MarketBeat
Medtronic Breaks Out Strong TAVR Data at ACC - Medical Device and Diagnostic industry
Top Stock Reports for Mastercard, Medtronic & HCA Healthcare - MSN
Medtronic (NYSE:MDT) TAVR System Shows Strong Five-Year Performance Despite 3% Price Dip - Yahoo
Stifel maintains Hold on Medtronic stock, sets $87 target By Investing.com - Investing.com UK
Medtronic Aortic Valve Replacement Device Shows Improvements Over Surgery in Heart Patients - MarketScreener
Medtronic plc (NYSE:MDT) Shares Sold by Meeder Asset Management Inc. - MarketBeat
Medtronic plc (MDT): Among the Best Dividend Aristocrat Stocks with Over 3% Yield - Insider Monkey
Medtronic Evolut™ TAVR system shows durable clinical outcomes and outstanding valve performance at five years in low-risk aortic stenosis patients - Medtronic
Prediction: Buying Medtronic Today Will Set You Up for Life - The Motley Fool
Prestige Wealth Management Group LLC Has $344,000 Stock Position in Medtronic plc (NYSE:MDT) - MarketBeat
Fed. Circ. Revives Recor's PTAB Challenge To Medtronic IP - Law360
Medtronic (MDT) Increases Despite Market Slip: Here's What You Need to Know - Yahoo Finance
Medtronic shares trade in green after seven straight days of losses - Seeking Alpha
Otsuka Gets Another Shot Challenging Medtronic Patent's Validity - Bloomberg Law News
Medtronic: A Great Business, But With Low Growth - Seeking Alpha
Is Medtronic plc (MDT) the Best Consistent Dividend Stock to Buy? - Insider Monkey
Ex-Dividend Reminder: Dick's Sporting Goods, Medtronic and DENTSPLY SIRONA - Nasdaq
Medtronic rolls out Affera PFA system in Sweden with more Nordic countries to follow - Mass Device
The Zacks Analyst Blog Boston Scientific, Abbott and Medtronic - Yahoo Finance
Recent U.S. Food and Drug Administration (FDA) approvals - Today's Medical Developments
메드트로닉 (MDT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.05%
0.46%
자본화:
|
볼륨(24시간):